Next Science Limited is a medical technology company headquartered in Sydney, Australia, with a research and development centre in Florida, USA. It is listed on the ASX under ASX Code ‘NXS’. Next Science’s primary focus is the development and continued commercialisation of its proprietary XbioTM technology to reduce the impact of biofilm based infections in human health.

Reporting Calendar

Reporting date Details of report
31 July 2019 Quarterly Report
30 August 2019 Half-Yearly Report
31 October 2019 Quarterly Report
31 January 2020 Quarterly Report
28 February 2020 Preliminary Final Report
31 March 2020 Audited Accounts/Auditor’s Report/Directors’ Report
30 April 2020 Annual Report / Quarterly Report

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 9375 7989
E: investorqueries@nextscience.com

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474